Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Prevalence of stroke among patients with chronic kidney disease, Taif, Saudi Arabia

Adnan A. Mubaraki, Waad D. Alotaibi, Afnan K. Sibyani, Ghaida T. Alrbaiai, Haneen S. Almalki, Hashim M. Atallah, Abdullah S. Basfar, Asrar Alqaedi, Hisham A. Althobaiti, Mohammed M. Algethami and Youssef A. Althobaiti
Saudi Medical Journal November 2023, 44 (11) 1139-1144; DOI: https://doi.org/10.15537/smj.2023.44.11.20230206
Adnan A. Mubaraki
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Waad D. Alotaibi
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Waad D. Alotaibi
  • For correspondence: [email protected]
Afnan K. Sibyani
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ghaida T. Alrbaiai
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haneen S. Almalki
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hashim M. Atallah
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdullah S. Basfar
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asrar Alqaedi
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisham A. Althobaiti
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed M. Algethami
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Youssef A. Althobaiti
From the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

Objectives: To evaluate the prevalence of stroke among chronic kidney disease (CKD) patients in Taif, Saudi Arabia.

Methods: A multicentric retrospective study was carried out from May 2021 to August 2022 on 4 dialysis centers in Taif, Saudi Arabia. With a total of 1857 CKD patients (aged ≥18 years old) participated in this study. Data were collected by reviewing patients’ files.

Results: Approximately 98.3% of the participants had severely decreased glomerular filtration rate. Approximately 49.1% of them were on dialysis; the majority of them (87.2%) underwent hemodialysis. The prevalence of stroke in these CKD patients was 8.3%. Ischemic stroke was the most frequently reported issue (81.2%). Ischemic stroke was comparatively more frequently observed in peritoneal dialysis patients (12.1%); whereas hemorrhagic stroke was more on hemodialysis patients with statistically significant association (p=0.029). However, there was no significant association between the prevalence of stroke and stages of CKD.

Conclusion: The prevalence of stroke in our cohort was 8.3%, and the majority of cases were ischemic strokes. Furthermore, ischemic strokes were more frequent in peritoneal dialysis patients, whereas hemorrhagic strokes occurred more frequently in hemodialysis patients with a statistically significant association.

Keywords:
  • prevalence
  • chronic kidney disease
  • renal failure
  • end-stage renal disease
  • glomerular filtration
  • cerebrovascular disease
  • stroke

Chronic kidney disease (CKD) is an irreversible change in the function or structure of the kidneys. An adult patient is diagnosed to have CKD when the glomerular filtration rate (GFR) is less than 60 ml/min/1.73 m2 for 3 months or more. There are 5 stages of CKD according to GFR, in end-stage renal disease (ESRD) the patient needs to be in maintenance dialysis.1 The prevalence of CKD has been increasing in the last few years. Chronic kidney disease is estimated to affect approximately 1.72 million people in Saudi Arabia.2 It is associated with many complications such as cardiovascular disease (CVD), cognitive dysfunction, and hospitalization, which may increase mortality and morbidity rates.3

Stroke is one of the major public health concerns worldwide in CKD patients; a meta-analysis of studies involving more than 2 million patients found a clear correlation between a declining renal function and a higher risk of stroke.4 Furthermore, reduced glomerular filtration levels increases the risk of stroke by approximately 40%, while proteinuria raises the risk by approximately 70%, according to cohort studies and trials.5

Patients on dialysis for ESRD have an 8-10 times higher risk of stroke than the general population, with rates ranging from 10-33 per 1,000 patient in reported studies.6 Wang et al7 showed that the incidence of ischemic and hemorrhagic strokes is higher in patients on peritoneal dialysis (PD) or hemodialysis (HD) in comparison to the general population.

Moreover, Ozelsancak et al8 reported in their study that out of 139 patients in hemodialysis, 65 (24.62%) had ischemic stroke and 25 (9.47%) had a hemorrhagic stroke. Peritoneal dialysis was associated with a 16% lower risk of hemorrhagic stroke compared to HD.9

Until now, the prevalence of stroke in CKD in Saudi Arabia is uncertain. Our aim in this study is to evaluate the prevalence of stroke among CKD patients in Taif, Saudi Arabia.

Methods

This is a multicentric retrospective study aimed to investigate the prevalence of stroke among CKD patients and compare stroke prevalence between patients on HD and PD. This study was carried out in May 2021 - August 2022 (with a sample size of 1857) at 4 dialysis centers (King Abdulaziz Specialist Hospital, King Faisal Medical Complex, Prince Mansour Military Hospital, and Alhada Armed Forced hospital) in Taif, Saudi Arabia. Ethical approval was obtained from the ethical committee of Health Affairs in Taif, Saudi Arabia. All procedures were carried out according to principles of Helsinki Declaration.

Inclusion criteria were all CKD patients aged ≥18 years old and who agreed to participate. Exclusion criteria were all those people not CKD, less than 18, and who refuse to participate.

Information was collected from the medical record of all CKD patients who met our inclusion criteria. Our data include information on demographics (age, gender, nationality, marital status, level of education, and body mass index), and the presence of any comorbidities (namely, hypertension, diabetes mellitus, CVD, dementia, hematological disorders, malignant disorders, and more). Specific information regarding CKD was obtained (namely, duration of illness, stage, and GFR). Dialysis status includes dialysis type and treatment duration. Information on the presence of stroke was obtained; if present, further information was collected regarding the type, whether it was hemorrhagic or ischemic, and duration of stroke.

Statistical analysis

Data was analyzed using the Statistical Package for the Socail Sciences, version 23 for Windows (IBM Corp., Armonk, NY, USA). Descriptive statistics were used in the form of frequencies and percentages. Mean and standard deviation was used for representing the continuous variables. Pearson’s Chi-square test was used to assess the relationship between categorical variables. A multivariate regression model was carried out to analyze the risk factors for stroke in CKD patients. A p-value of <0.05 was considered significant.

Results

Our analysis included CKD patients’ data from 4 tertiary care hospitals in Taif, Saudi Arabia. The mean age of the patients was 60.3±18.9 years. The socio-demographic data showed that 66.2% of the patients were over 55 years old, 59.3% were males, 50.4% were married, 6.3% had a primary school education level or were illiterate, and 19.4% were obese (Table 1). The most commonly reported comorbidity was hypertension (78.9%), followed by diabetes (41.5%), and ischemic heart disease (25.1%).

View this table:
  • View inline
  • View popup
Table 1

- Sociodemographic details.

The clinical characteristics of the CKD patients showed that approximately 1010 (54.4%) had end-stage renal disease (ESRD) and remaining had CKD. The GFR was found to be severely decreased in 98.3% of the patients, where it was significantly higher among ESRD patients compared to CKD patients (p<0.01). The total of patients who were on dialysis were 911 (49.1%), where the majority (95.3%) were in ESRD (p<0.01).

The majority of patients who were on dialysis underwent hemodialysis (87.2%), where 95% of those were ESRD patients and approximately 76.1% of those who had PD were CKD patients (p<0.01). In our cohort, 9 patients were on dialysis for more than 10 years and all of them were ESRD patients (p<0.01, Table 2).

View this table:
  • View inline
  • View popup
Table 2

- Clinical characteristics related to chronic kidney disease.

The prevalence of stroke in these CKD patients was found to be 8.3%. Approximately 48.7% of these 154 patients had a stroke in less than one year, and 7.8% had its onset for more than 10 years. Ischemic stroke was the most reported stroke among these patients (81.2%, Table 3).

View this table:
  • View inline
  • View popup
Table 3

- Prevalence of stroke and its characteristics.

When we assessed the relationship between the prevalence of stroke with stages of CKD, duration of dialysis, and type of dialysis, no statistically significant association was observed (p>0.05, Table 4). There was also no statistical significance observed between the duration of dialysis and the type of stroke (p>0.05). However, ischemic stroke was comparatively more frequent in the patients on PD (12.1%), whereas hemorrhagic stroke was more frequent in the patients on HD; this result showed a statistically significant association (p=0.029, Table 5).

View this table:
  • View inline
  • View popup
Table 4

- Relationship of stroke with chronic kidney disease and dialysis.

View this table:
  • View inline
  • View popup
Table 5

- Relationship between type of stroke and dialysis.

A multivariate logistic regression model was carried out to assess the risk factors for stroke among CKD patients. It was found that age above 55 years (odds ratio [OR]=3.30, 95% confidence interval [CI]: [1.86-5.86], p<0.001), being married (OR=1.27, 95% CI: [0.82-2.60], p=0.001), hypertension (OR=3.11, 95% CI: [1.58-6.12], p=0.001), and ischemic heart disease (OR=1.38, 95% CI: [0.95-2.00], p=0.043) were independently associated with stroke (Table 6).

View this table:
  • View inline
  • View popup
Table 6

- Multivariate logistic regression model (independent variable = stroke).

Discussion

Chronic kidney disease is a well-known highly prevalent medical issue associated with many complications (namely, cerebrovascular disease, cognitive dysfunction, and hospitalization), which may increase mortality and morbidity rates.10 Stroke is considered to be one of the major public health concerns in CKD patients; therefore, in this study, we aimed to evaluate the prevalence of stroke among CKD patients.

When we assessed the severity of GFR among the CKD patients, we found that 98.3% of them could be classified as having severely decreased GFR. The observed percentage is very high, which prompted us to more carefully evaluate the patients with mild to moderate decrease in GFR to prevent the progression to the severe stage. Moreover, another study on 778 patients showed that among the 639 patients with brain ischemia, 22% of them had severely decreased GFR.11

In addition, 49.1% of the patients who participated in our study were on dialysis, and most of them were on HD (87.2%). In another study on 148 participants with ESRD, the percentage of the patients on HD was 85.1%, which is comparable to our results.12

Furthermore, we noticed that the duration of dialysis in our study was mostly less than one year, which may indicate that most of the patients (especially those with a stroke) presented later in the course of their CKD. A study carried out on elderly patients on dialysis showed that the peak of stroke occurred during the first 30 days of initiating dialysis.10

In our study, the prevalence of stroke among CKD patients was 8.3%, which is higher compared to that in a study carried out in the United States that reported a prevalence of 6.1%.13 This discrepancy may be due to the ethnicity effect.14 However, 81.2% of our stroke patients had an ischemic stroke, which is comparable to the results reported by Ohasam et al,15 who stated that 70.5% of their CKD patients developed an ischemic stroke.

This well-known association between declined renal function and ischemic stroke has been investigated and explained in many studies. In the literature, the pathogenesis has been explained by several factors such as deterioration of the vascular endothelial system, accumulation of indoxyl sulfate, and alteration of prothrombotic mechanisms.4,16 Our study found no association between stages of CKD and the prevalence of stroke. However, a meta-analysis of 21 articles (with 14 of them assessing ESRD patients with an eGFR value of <60 ml/min/1.73 m2, found an increased prevalence of stroke in stages III-IV and among ESRD patients. In our cohort, only 49.1% were ESRD patients; among those, 41.4% underwent dialysis for a period that was less than one year, which may explain the discrepancy.17 In addition, our study revealed no relationship between stroke prevalence and the type of dialysis, which agrees with the study by Murray et al.10

Furthermore, a systemic review found that there was no significant association between the type of dialysis and the type of stroke, which contradicts our results.18 This discrepancy can be explained by the difference in the types of carried out studies. Furthermore, the above-mentioned study reported a low risk of hemorrhagic stroke in PD patients, which matches our results.18 However, the high bleeding tendency in HD patients has been reported in many studies, which may be due to hemodynamic instability.19,20

Overall, age above 55 years, hypertension, and CVD are independently related to stroke. Another study has also reported that older age, diabetes, and CVD are independently associated with stroke.21 A previous study showed that patients with CKD and hypertension may experience unfavorable cardiovascular outcomes, especially stroke.5 Moreover, the mainstay of both primary and secondary stroke prevention is controlling hypertension.6 However, patients with CKD are a high-risk population for stroke and, thus, should receive clinical priority.5

Study limitations

In this study, the data were obtained from medical records; however, not all records were fully informative regarding the CKD stage or GFR, which may prone our cohort to misclassification. We recommend that future studies should include serum creatinine levels in the data collection process to calculate eGFR.

In conclusion, our study showed that ischemic stroke is more prevalent among patients with CKD. Furthermore, a statistically significant association between ischemic stroke with PD and hemorrhagic stroke with HD was evident. Stroke prevalence was neither associated with the stage or duration of CKD nor with the type of dialysis. These results identify CKD patients as a high-risk population for stroke regardless of their disease course and type of dialysis.

Acknowledgment

The authors gratefully acknowledge Dr. Muhanna J. Altalhi, Dr. Ahmed H. Alsuhaymi, Dr. Qussi H. Omer, Dr. Razan A. Almakki, Dr. Mrooj A. Suwayyid, Dr. Abdullah S. Alkhtani, and Dr. Muhanna A. Alhusayni for their valuable contribution in the data collection process. The authors also would like to thank Falcon Scientific Editing for their English language editing.

Footnotes

  • Disclosure. Authors have no conflict of interests, and the work was not supported or funded by any drug company.

  • Received September 2, 2023.
  • Accepted October 5, 2023.
  • Copyright: © Saudi Medical Journal

This is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

References

  1. 1.↵
    1. Drawz P,
    2. Rahman M
    . In the clinic. Chronic kidney disease. Ann Intern Med 2009; 150: ITC2-1-15; quiz ITC2-16.
  2. 2.↵
    1. Cyrus C,
    2. Al-Mueilo S,
    3. Vatte C,
    4. Chathoth S,
    5. Li YR,
    6. Qutub H, et al.
    Assessing known chronic kidney disease associated genetic variants in Saudi Arabian populations. BMC Nephrol 2018; 19: 88.
    OpenUrl
  3. 3.↵
    1. Singh AK
    . Chronic kidney disease. [Updated 2010; 2009 Dec 16]. Available from: https://www.sciencedirect.com/science/article/abs/pii/B9780323041072501241?via%3Dihub
  4. 4.↵
    1. Chelluboina B,
    2. Vemuganti R
    . Chronic kidney disease in the pathogenesis of acute ischemic stroke. J Cereb Blood Flow Metab 2019; 39: 1893–1905.
    OpenUrl
  5. 5.↵
    1. Kelly D,
    2. Rothwell PM
    . Disentangling the multiple links between renal dysfunction and cerebrovascular disease. J Neurol Neurosurg Psychiatry 2020; 91: 88–97.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Power A
    . Stroke in dialysis and chronic kidney disease. Blood Purif 2013; 36: 179–183.
    OpenUrl
  7. 7.↵
    1. Wang HH,
    2. Hung SY,
    3. Sung JM,
    4. Hung KY,
    5. Wang JD
    . Risk of stroke in long-term dialysis patients compared with the general population. Am J Kidney Dis 2014; 63: 604–611.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Ozelsancak R,
    2. Micozkadioglu H,
    3. Torun D,
    4. Tekkarismaz N
    . Cerebrovascular events in hemodialysis patients; a retrospective observational study. BMC Nephrol 2019; 20: 466.
    OpenUrl
  9. 9.↵
    1. Boonpheng B,
    2. Thongprayoon C,
    3. Cheungpasitporn W
    . The comparison of risk of stroke in patients with peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. J Evid Based Med 2018; 11: 158–168.
    OpenUrl
  10. 10.↵
    1. Murray AM,
    2. Seliger S,
    3. Lakshminarayan K,
    4. Herzog CA,
    5. Solid CA
    . Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol 2013; 24: 1166–1173.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Tsukamoto Y,
    2. Takahashi W,
    3. Takizawa S,
    4. Kawada S,
    5. Takagi S
    . Chronic kidney disease in patients with ischemic stroke. J Stroke Cerebrovasc Dis 2012; 21: 547–550.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Kurella Tamura M,
    2. Meyer JB,
    3. Saxena AB,
    4. Huh JW,
    5. Wadley VG,
    6. Schiller B
    . Prevalence and significance of stroke symptoms among patients receiving maintenance dialysis. Neurology 2012; 79: 981–987.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Ovbiagele B
    . Chronic kidney disease and risk of death during hospitalization for stroke. J Neurol Sci 2011; 301: 46–50.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Tsai CF,
    2. Thomas B,
    3. Sudlow CL
    . Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology 2013; 81: 264–272.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Nakayama M,
    2. Metoki H,
    3. Terawaki H,
    4. Ohkubo T,
    5. Kikuya M,
    6. Sato T, et al.
    Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study. Nephrol Dial Transplant 2007; 22: 1910–1915.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Kusano E
    . Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon. Clin Exp Nephrol 2011; 15: 627–633.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Lee M,
    2. Saver JL,
    3. Chang KH,
    4. Liao HW,
    5. Chang SC,
    6. Ovbiagele B
    . Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010; 341: c4249.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Zhan X,
    2. Yang M,
    3. Chen Y,
    4. Zhang L,
    5. Yan C,
    6. Wang Y
    . Comparison of risk of stroke in patients treated with peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Ren Fail 2019; 41: 650–656.
    OpenUrl
  19. 19.↵
    1. Moustapha F,
    2. Tall LA,
    3. Yaya K,
    4. Moustapha CM,
    5. Mohamed SS,
    6. Maria F, et al.
    Intradialytic hypertension: prevalence and associated factors in chronic hemodialysis patients in Senegal. Open J Nephrol 2018; 8: 29–37.
    OpenUrl
  20. 20.↵
    1. McIntyre CW,
    2. Goldsmith DJ
    . Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension? Kidney Int 2015; 87: 1109–1115.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Fu J,
    2. Huang J,
    3. Lei M,
    4. Luo Z,
    5. Zhong X,
    6. Huang Y, et al.
    Prevalence and impact on stroke in patients receiving maintenance hemodialysis versus peritoneal dialysis: a prospective observational study. PLoS One 2015; 10: e0140887.
    OpenUrl
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 44 (11)
Saudi Medical Journal
Vol. 44, Issue 11
1 Nov 2023
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of stroke among patients with chronic kidney disease, Taif, Saudi Arabia
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Prevalence of stroke among patients with chronic kidney disease, Taif, Saudi Arabia
Adnan A. Mubaraki, Waad D. Alotaibi, Afnan K. Sibyani, Ghaida T. Alrbaiai, Haneen S. Almalki, Hashim M. Atallah, Abdullah S. Basfar, Asrar Alqaedi, Hisham A. Althobaiti, Mohammed M. Algethami, Youssef A. Althobaiti
Saudi Medical Journal Nov 2023, 44 (11) 1139-1144; DOI: 10.15537/smj.2023.44.11.20230206

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prevalence of stroke among patients with chronic kidney disease, Taif, Saudi Arabia
Adnan A. Mubaraki, Waad D. Alotaibi, Afnan K. Sibyani, Ghaida T. Alrbaiai, Haneen S. Almalki, Hashim M. Atallah, Abdullah S. Basfar, Asrar Alqaedi, Hisham A. Althobaiti, Mohammed M. Algethami, Youssef A. Althobaiti
Saudi Medical Journal Nov 2023, 44 (11) 1139-1144; DOI: 10.15537/smj.2023.44.11.20230206
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prolonged flight exposure and its effects on sinonasal health among aircrew members
  • Identifying individuals at risk of post-stroke depression
  • Hematological parameters in recent and past dengue infections in Jazan Province, Saudi Arabia
Show more Original Article

Similar Articles

Keywords

  • prevalence
  • chronic kidney disease
  • renal failure
  • end-stage renal disease
  • glomerular filtration
  • cerebrovascular disease
  • stroke

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire